Common Side Effects in Pediatric Patients
Enbrel (etanercept) in children, approved for polyarticular juvenile idiopathic arthritis (JIA) in patients 2 years and older, commonly causes injection site reactions like redness, itching, pain, or swelling, affecting up to 37% of kids in trials.[1][2] Upper respiratory infections occur in about 16-21%, and headaches in 12-26%.[2] Other frequent issues include accidental injuries, vomiting, and rhinitis.[1]
Serious Risks and Infections
Serious infections, including sepsis, cellulitis, pneumonia, and tuberculosis, arise in 1-6% of pediatric cases, with some fatal outcomes reported.[1][2] Enbrel suppresses the immune system, raising opportunistic infection risks like invasive fungal infections.[1] Screening for latent TB and hepatitis B is required before starting.[2]
Autoimmune and Blood-Related Issues
New or worsening autoimmune conditions, such as lupus-like syndrome, vasculitis, or demyelinating disorders (e.g., optic neuritis, multiple sclerosis), can develop.[1][2] Blood disorders like pancytopenia, thrombocytopenia, or aplastic anemia occur rarely but require immediate monitoring; some cases are fatal.[1]
Cancer and Malignancy Concerns
Lymphomas and other malignancies have been observed at higher rates in children with JIA on TNF blockers like Enbrel, though causality is unclear—rates were 3.5 times higher than the general population in some studies.[1][2] Long-term data show combined solid and hematologic cancers at 0.7 per 100 patient-years.[2]
Other Notable Effects
Allergic reactions (hives, swelling, anaphylaxis) affect less than 2%.[1] Liver enzyme elevations, heart failure worsening, and cytopenias need regular blood tests.[2] In trials up to 8 years, no unique pediatric risks beyond adults emerged, but growth retardation or neurologic events warrant vigilance.[2]
Monitoring and Precautions for Kids
Pediatric dosing starts at 0.8 mg/kg weekly (max 50 mg), with close monitoring for infections and blood counts.[2] Discontinue if serious infection or malignancy occurs. Live vaccines are contraindicated during treatment.[1] Consult FDA labeling for full details, as post-marketing reports continue to evolve.[1][2]
[1]: FDA Enbrel Label
[2]: Enbrel Prescribing Information - Pediatric Section